Advisory Board and Editors Cell Biology
Leticia Costa-Lotufo
Dr. Costa-Lotufo is a full professor at the Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo. Her lab is focused on the discovery of new anticancer compounds from Brazilian marine biodiversity and studies on their mechanisms of action. She coordinate a multidisciplinary project to access marine microorganisms diversity and biotechnological potential along the Brazilian coast and islands. Dr. Costa-Lotufo’s activities include the supervision of undergraduate and graduate students and post-doctoral fellows. She has published book chapters, review articles and more than 230 articles in peer-reviewed journals. On 2010, Dr. Costa-Lotufo was nominated as a young scientist of the Brazilian Academy of Science (2010-2014).
Wei Cui
Wei CUI, Ph.D.
Extension Associate Professor
Principal Investigator (Independent)
Director, Animal Models Core Facility
at University of Massachusetts Amherst
https://www.umass.edu/veterinary-animal-sciences/about/directory/wei-cui
More than 16 years of experience in mammalian oocyte and pre-implantation embryo development. Created live transgenic cloned goats by somatic cell nuclear transfer (SCNT). Generated multiple Knockout and Knock-in rat and mouse lines by ZFN, TALEN, and CRISPR/Cas9.
Academic Editor for PeerJ;
Associate Editor for Journal of Cellular and Molecular Medicine;
Associate Editor for Reproduction and Fertility;
Associate Editor for Animal Reproduction-Theriogenology, Frontiers in Veterinary Science;
Academic Editor for PLOS ONE.
Served as Peer Reviewer for more than 40 journals 180 times, as well as Editors for over 50 times.
https://www.webofscience.com/wos/author/record/169586
https://publons.com/author/1174231/wei-cui#profile
https://www.umass.edu/veterinary-animal-sciences/about/directory/wei-cui
Keywords: Mammalian oogenesis, Preimplantation Embryo, Oocyte maturation, CRISPR/Cas9, Knockout, Knock-in, Oocyte-specific conditional knockout, Somatic Cell Nuclear Transfer (SCNT), Oocyte spontaneous activation, Cell cycle, Oocyte aging, Animal models, Epigenetics, Toxicology, Cell culture, Fertilization, Micromanipulation, RNAi, Knockdown, Animal reproduction, Genome editing, Blastocyst, Cell lineage
Krystyna Dąbrowska
Affiliation: Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland (Bacteriophage Laboratory).Position: professor.
Current field of interest: non-bactericidal effects of phages in mammals; i.e. phage molecular biology tools for studies of phage impact on immunological system and other physiological aspects in mammals.
Anissa Daliry
Dr. Anissa Daliry is a biologist at the Federal College of Pernambuco (UFPE) and holds a master's degree and a PhD in cellular and molecular biology from FIOCRUZ and a postdoctoral degree from Biophysics/UFRJ. Dr. Anissa is a permanent professor of Cell and Molecular Biology program, IOC/FIOCRUZ (level 7/ CAPES) and young scientist of our state/FAPERJ (2021-2024). Her main research focus is to study molecular, physiological pathways and mechanisms involved in the development of cardiovascular and metabolic diseases such as obesity, metabolic syndrome, diabetes, hypertension, non-alcoholic fatty liver disease (NAFLD) and Chagas disease. She performs pre-clinical and clinical studies. She coordinates the postgraduate course "Cardiovascular and Metabolic Diseases: from bench to the bedside." She is a reviewer for 13 indexed international journals. Since 2020, she has collaborated in the Longitudinal Study of Brazilian Health, ELSA-BRASIL. She is also a member of the Liver Center and the Brazilian Society of Pharmacology and Experimental Therapeutics (SBFte). She develops projects in technological innovation with the development of a medical device for the quantification of hepatic steatosis. Dr. Anissa is a member of the research directory group entitled: Longitudinal Study of Adult Health - RJ/Fiocruz Research Center, coordinated by Dr. Rosane Griep/IOC and leader of the CNPq research group entitled: Study group on pathophysiology and therapy of chronic non-communicable and infectious diseases.
Mary Dasso
Senior Investigator in the Laboratory of Gene Regulation and Development, National Institute for Child Health and Human Development.
Melissa J Davis
Associate Professor Melissa Davis is a computational biologist and Laboratory Head in the Bioinformatics Division of the Walter and Eliza Hall Institute of Medical Research. Her background is in genetics and computational cell biology with expertise in the analysis of genome-scale molecular networks, systems biology, and knowledge-based modelling of regulatory networks.
In 2014, Melissa was awarded a four year National Breast Cancer Foundation Career Development Fellowship, and took up a position as Senior Research Fellow in Computational Systems Biology at the University of Melbourne, before moving to the Walter and Eliza Hall Institute for Medical Research as a Laboratory Head in 2016. Melissa specialises in the integration of genomic, transcriptomic, and proteomic data with knowledge-based network models to understand the regulatory logic of mammalian systems.
Maria A. Deli
Scientific advisor at the Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences in Szeged, Hungary. Head of the Biological Barriers Research Group. Honorary professor at the University of Szeged.
Carminia Maria Della Corte
-09/01/2018-current: Postdoc researcher at MDACC, Houston, Thoracic Head and Neck department, PI: Lauren Byers
-05/07/2012 – 04/07/2017: Residency in Medical Oncology (50/50 cum laude) at Second University of Naples, research thesis in:“Role of Hedgehog pathway in the acquisition of resistance to EGFR inhibitors in EGFR mutant non small cell lung cancer models”
- 10/10/2011: Degree in Medicine (110/110 cum laude), at Second University of Naples, research thesis in “Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors”
-Multiple first-name and co-authored publications in Transnational research in Oncology field.
Robert J. Deschenes
Professor and Chair of the Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Fred Wright Professor of Cancer Biology
Sule Dogan
Dr. Sule Dogan has BSc in Biology from Ankara University, MSc in Embryology and another Master’s degree in science education, both from Dokuz Eylul University in Turkey. After completing her Andrology and Embryology training, she worked at the IVF Clinic of Dokuz Eylul University Medical School between 2007 and 2009. She completed her PhD in Life Sciences/ Genetics program at Mississippi State University. Dr. Dogan joined IVF Michigan Fertility Centers as an embryologist in 2013, started serving as the quality control and laboratory supervisor in 2015 and then became the laboratory director in 2019. She has opened up new andrology laboratories, trained many andrologists and embryologists. She is currently serving as the director of laboratory operations in many locations of IVF Michigan and IVF Ohio Fertility Centers. Dr. Dogan is a certified by ABB as Technical Supervisor in Andrology and Embryology, and as High Complexity Lab Director (HCLD). She has many publications in international journals, including many book chapters. Dr. Dogan has been serving as a reviewer for scientific journals and conferences since 2010.
Ana I. Duarte
Post-Doc Fellow at Center for Neuroscience and Cell Biology (since 2007), Coimbra, Portugal. Visiting researcher at Neuronal Survival Unit, Wallenberg Neuroscience Center, Lund Medical School, Lund, Sweden (Sept 2008 - May 2009). PhD and MSc in Biology (Cell Biology) by University of Coimbra, Portugal (in 2007 and 2002, respectively). Degree in Biology by University of Coimbra, Portugal (in 1998).
Elaine A Dunlop
Dr. Elaine Dunlop is a Lecturer in the Division of Cancer and Genetics at Cardiff University. She received her PhD in Cancer Research from Queen's University, Belfast and her research now centres on the inherited genetic conditions, Tuberous Sclerosis Complex and Birt-Hogg-Dubé syndrome where patients are predisposed to develop cysts and tumours. She is interested in the crossover between the cell signalling observed in these genetic diseases and the pathways which are at fault in cancer, with a focus on mTORC1 growth pathways, autophagy and the tumour microenvironment.